6. Glycemic Targets: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee·2022·Diabetes Care

Cited by (1,002)

Items 101–200 of 1,002

  1. "This Girl is on Fire"
    Alyson Leigh Young, Andrew Miller · 2019 · CHI Conference on Human Factors in Computing Systems
  2. Rates of hypoglycemic and hyperglycemic emergencies among U.S. adults with diabetes, 2011–2020
    McCoy, Rozalina G., Herrin, Jeph, Galindo, Rodolfo J., Swarna, Kavya Sindhu, Umpierrez, Guillermo E., Golden, Sherita Hill, O’Connor, Patrick J. · 2023 · Diabetes Care
  3. Evolution of Gestational Diabetes Mellitus across Continents in 21st Century
    Dłuski, Dominik Franciszek, Ruszała, Monika, Rudziński, Gracjan, Pożarowska, Kinga, Brzuszkiewicz, Kinga, Leszczyńska-Gorzelak, Bożena · 2022 · International Journal of Environmental Research and Public Health
  4. Diabetic Kidney Disease Back in Focus: Management Field Guide for Health Care Professionals in the 21st Century
    Radica Z. Alicic, Susanne B. Nicholas · 2022 · Mayo Clinic Proceedings
  5. The relationship between SGLT2 and systemic blood pressure regulation
    Priscilla Ahwin, Diana Martinez · 2024 · Hypertension Research
  6. Pattern of electrolyte imbalance in Type 2 diabetes patients: Experience from a tertiary care hospital
    Rashid Naseem Khan, Farhana Saba, Syedhh Fatima Kausar, Mohammad Hassan Siddique · 2019 · Pakistan Journal of Medical Sciences
  7. Sleep and Glycemia in Youth With Type 1 Diabetes
    Kaitlyn Rechenberg, Stephanie Alisha Griggs, Sangchoon Jeon, Nancy Schmieder Redeker, Henry Klar Yaggi, Margaret J. Grey · 2020 · Journal of Pediatric Health Care
  8. Automated Insulin Delivery for Hypoglycemia Avoidance and Glucose Counterregulation in Long-Standing Type 1 Diabetes with Hypoglycemia Unawareness
    Anneliese J. Flatt, Amy J. Peleckis, CORNELIA V. DALTON-BAKES, Huong-Lan Nguyen, Sarah Ilany, AUSTIN M. MATUS, Susan Kohl Malone, Namni Goel, Sooyong Jang, James E. Weimer et al. · 2023 · Diabetes Technology & Therapeutics
  9. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes
    Virginia Bellido, Eva Aguilera, Roque Cardona‐Hernandez, Gonzalo Díaz-Soto, Noemí González Pérez de Villar, María José Picón César, Francisco Javier Ampudia‐Blasco · 2022 · Journal of Diabetes Science and Technology
  10. Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial
    Juan P. Frías, JaeDuk Choi, Julio Rosenstock, Luiza Popescu, Elisabeth Niemoeller, Isabel Muehlen-Bartmer, Seung Jae Baek · 2022 · Diabetes Care
  11. Impact of HbA1c Followed 32 Years From Diagnosis of Type 1 Diabetes on Development of Severe Retinopathy and Nephropathy: The VISS Study
    Hans J. Arnqvist, Malin C Westerlund, Mats G. Fredrikson, Johnny Ludvigsson, Maria Nordwall · 2022 · Diabetes Care
  12. Sex differences in the association of fasting glucose with HbA1c, and their consequences for mortality: A Mendelian randomization study
    Guoyi Yang, Shiu Lun Au Yeung, Catherine Mary Schooling · 2022 · EBioMedicine
  13. Association of Combined Healthy Lifestyles With Cardiovascular Disease and Mortality of Patients With Diabetes: An International Multicohort Study
    Yanbo Zhang, Xiong‐Fei Pan, Qi Lu, Yanxiu Wang, Tingting Geng, Yanfeng Zhou, Linda M. Liao, Zhou‐Zheng Tu, Jun‐Xiang Chen, Peng‐Fei Xia et al. · 2023 · Mayo Clinic Proceedings
  14. Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical trial
    Peter G. Jacobs, Navid Resalat, Wade W. Hilts, Gavin M. Young, JOSEPH A. LEITSCHUH, Joseph Pinsonault, Joseph El Youssef, Deborah L. Branigan, Virginia B. Gabo, Jae H. Eom et al. · 2023 · The Lancet Digital Health
  15. Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment
    Vanita R. Aroda, Robert H. Eckel · 2022 · Diabetes Obesity and Metabolism
  16. A multicenter randomized trial evaluating the insulin-only configuration of the bionic pancreas in adults with type 1 diabetes
    Bionic Pancreas Research Group, Kruger, Davida, Kass, Alex, Lonier, Jacqueline, Pettus, Jeremy, Raskin, Philip, Salam, Maamoun, Trikudanathan, Subbulaxmi, Zhou, Keren, Russell, Steven J. et al. · 2022 · Diabetes Technology & Therapeutics
  17. Visit-to-visit glycated hemoglobin A1c variability in adults with type 2 diabetes: A systematic review and meta-analysis
    Qu, Furong, Shi, Qingyang, Wang, Yang, Shen, Yanjiao, Zhou, Kaixin, Pearson, Ewan R., Li, Sheyu · 2022 · Chinese Medical Journal
  18. Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control
    Giuseppe Lepore, Alessandro Rossini, Rosalia Bellante, Anna Maria Corsi, Cristiana Scaranna, Alessandro Roberto Dodesini, Roberto Trevisan · 2022 · Acta Diabetologica
  19. Onset age of diabetes and incident dementia: A prospective cohort study
    Wang, Yongqian, Li, Chenglong, Liang, Jie, Gao, Darui, Pan, Yang, Zhang, Wenya, Zhang, Yang, Zheng, Fanfan, Xie, Wuxiang · 2023 · Journal of Affective Disorders
  20. Baseline modern medical management in the BEST-CLI trial
    Matthew T. Menard, Michael R. Jaff, Alik M. Farber, Kenneth Rosenfield, Michael S. Conte, Christopher J. White, Joshua A. Beckman, Niteesh K. Choudhry, Leonardo Clavijo, Thomas S. Huber et al. · 2023 · Journal of Vascular Surgery
  21. Association of long-term air pollution exposure with the risk of prediabetes and diabetes: Systematic perspective from inflammatory mechanisms, glucose homeostasis pathway to preventive strategies
    Yayuan Mei, Ang Li, Jiaxin Zhao, Quan Zhou, Meiduo Zhao, Jing Xu, Runkui Li, Yanbing Li, Kai Li, Xiaoyu Ge et al. · 2022 · Environmental Research
  22. Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project
    Katarzyna Nabrdalik, Hanna Kwiendacz, Justyna Moos, Łukasz Moos, Justyna Kulpa, Zenon Brzoza, Tomasz P. Stompór, Janusz Gumprecht, Gregory Y.H. Lip · 2023 · Current Problems in Cardiology
  23. Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
    Shah, Viral N., Peters, Anne L., Umpierrez, Guillermo E., Sherr, Jennifer L., Akturk, Halis Kaan, Aleppo, Grazia, Bally, Lia, Cengiz, Eda, Cinar, Ali, Dungan, Kathleen et al. · 2025 · Journal of Diabetes Science and Technology
  24. Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative
    Nikhil Singh, Chubing Zeng, Juan Pablo Lewinger, A. Wolfson, David M. Shavelle, Fred A. Weaver, Parveen K. Garg · 2019 · Journal of Vascular Surgery
  25. Association of Diabetes Mellitus Status and Hyperglycemia With Symptomatic Knee Osteoarthritis
    Jiazhen Zheng, Xihao Huang, Jinghan Huang, Bingyao Meng, Fu‐Rong Li, Huamin Liu, Liren Chen, Rui Zhou, Mengchen Zou, Xianbo Wu · 2022 · Arthritis Care & Research
  26. Intuitive eating is associated with weight and glucose control during pregnancy and in the early postpartum period in women with gestational diabetes mellitus (GDM): A clinical cohort study
    Dan Yedu Quansah, Justine Gross, Leah Gilbert, Céline Helbling, Antje Horsch, Jardena J. Puder · 2019 · Eating Behaviors
  27. Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits
    MEGHAN E. PAULEY, Kalie L. Tommerdahl, Janet K. Snell‐Bergeon, Gregory P. Forlenza · 2022 · Current Cardiology Reports
  28. The Impact of Carbamylation and Anemia on HbA1c’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease
    Mengyao Tang, Anders Hayden Berg, Eugene P. Rhee, Andrew S. Allegretti, Sagar U. Nigwekar, S. Ananth Karumanchi, James Phillip Lash, Sahir Kalim · 2022 · Diabetes Care
  29. Pharmacokinetic and Pharmacodynamic Characteristics of Insulin Icodec After Subcutaneous Administration in the Thigh, Abdomen or Upper Arm in Individuals with Type 2 Diabetes Mellitus
    Leona Plum‐Mörschel, Lizette Ravn Andersen, Solvejg L. Hansen, Ulrike Hövelmann, PATRICIA KRAWIETZ, Niels Rode Kristensen, Lars Lang Lehrskov, Hanne L. Haahr · 2023 · Clinical Drug Investigation
  30. Impact of preoperative glycometabolic status on outcomes in cardiac surgery: systematic review and meta-analysis
    Corazzari, Claudio, Matteucci, Matteo, Kołodziejczak, Michalina, Kowalewski, Mariusz, Formenti, Anna Maria, Giustina, Andrea, Beghi, Cesare, Barili, Fabio, Lorusso, Roberto · 2022 · The Journal of Thoracic and Cardiovascular Surgery
  31. Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes—So Why Is Their Uptake So Low?
    Aaron King, Eden M Miller · 2022 · Clinical Diabetes
  32. Use of Continuous Glucose Monitoring in Older Adults: A Review of Benefits, Challenges and Future Directions
    Lalita Prasad‐Reddy, Alvin Godina, Ashwin K. Chetty, Close Concerns, San Francisco, CA, USA, Diana Isaacs · 2022 · touchREVIEWS in Endocrinology
  33. Continuous glucose monitors and virtual care in high-risk, racial and ethnic minority populations: Toward promoting health equity
    Elizabeth A. Vrany, Felicia Hill‐Briggs, Patti L. Ephraim, Alyson K. Myers, Patricia Garnica, Stephanie L. Fitzpatrick · 2023 · Frontiers in Endocrinology
  34. The 2024 Flemish consensus on screening for gestational diabetes mellitus early and later in pregnancy
    Katrien Benhalima, Ina Geerts, Peggy Calewaert, Marijke Van Rijsselberghe, Dahae Lee, Niels Bochanen, Sabine Verstraete, Luk Buyse, Liesbeth Lewi, Rudi Caron et al. · 2024 · Acta Clinica Belgica
  35. Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study
    Riccardo Schiaffini, Annalisa Deodati, M. C. Nicoletti, Chiara Carducci, Paolo Ciampalini, Antonella Lorubbio, Maria Cristina Matteoli, Valentina Pampanini, Ippolita Patrizia Patera, Novella Rapini et al. · 2022 · Acta Diabetologica
  36. Diabetes: how to manage diabetic peripheral neuropathy
    Megha Gandhi, Emily L. Fargo, Lalita Prasad‐Reddy, Katherine M. Mahoney, Diana M. Isaacs · 2022 · Drugs in Context
  37. Analytical Challenges in Diabetes Management: Towards Glycated Albumin Point-of-Care Detection
    Andrea Rescalli, Elena Maria Varoni, Francesco Cellesi, Pietro Cerveri · 2022 · Biosensors
  38. Implementation of an Intensive Telehealth Intervention for Rural Patients with Clinic-Refractory Diabetes
    Elizabeth A. Kobe, Allison A. Lewinski, Amy S. Jeffreys, Valerie A. Smith, Cynthia J. Coffman, Susanne M. Danus, Elisabeth Sidoli, Beth D. Greck, LEANNE C. HORNE, David R. Saxon et al. · 2022 · Journal of General Internal Medicine
  39. Professional Competencies for Diabetes Technology Use in the Care Setting
    Shivajirao Prakash Patil, Anastasia Albanese-O’Neill, Kirsten Yehl, Jane Jeffrie Seley, Allyson S. Hughes · 2022 · The Science of Diabetes Self-Management and Care
  40. Patent analysis of digital sensors for continuous glucose monitoring
    Olena Litvinova, Magdalena Eitenberger, Aylin Bilir, Andy Wai Kan Yeung, Emil D. Parvanov, ArunSundar MohanaSundaram, Jarosław Olav Horbańczuk, Atanas G. Atanasov, Harald Willschke · 2023 · Frontiers in Public Health
  41. The Effectiveness of Continuous Glucose Monitoring Devices in Managing Uncontrolled Diabetes Mellitus: A Retrospective Study
    Andre Emanuilov Manov, Sukhjinder Chauhan, Gundip S Dhillon, Athena Dhaliwal, Sabrina Antonio, Ashrita Donepudi, Yema Jalal, Jonathan Nazha, Melissa Banal, Joseph House · 2023 · Cureus
  42. Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study
    Hope S. Rugo, Mafalda Oliveira, Sacha Jon Howell, Florence Dalenc, Javier Cortés, Henry Gómez, Xingjiang Hu, Komal L. Jhaveri, Петр Владимирович Криворотько, Sibylle Loibl et al. · 2024 · ESMO Open
  43. Primary Care Management of Patients With Type 2 Diabetes: Overcoming Inertia and Advancing Therapy With the Use of Injectables
    Tricia Santos Cavaiola, Yan Kiriakov, Timothy Reid · 2019 · Clinical Therapeutics
  44. Impact of the Complexity of Glucose Time Series on All-Cause Mortality in Patients With Type 2 Diabetes
    Jinghao Cai, Qing Yang, Jingyi Lu, Yun Shen, Chunfang Wang, Lei Chen, Lei Zhang, Wei Lu, Wei Zhu, Tian Xia et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  45. SGLT2 Inhibitors in the Treatment of Diabetic Kidney Disease: More than Just Glucose Regulation
    Jasna Klen, Vita Dolžan · 2023 · Pharmaceutics
  46. Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
    Menzen, Markus, Berentzen, Tina Landsvig, Catarig, Andrei-Mircea, Pieperhoff, Sebastian, Simon, Jörg, Jacob, Stephan · 2023 · Experimental and Clinical Endocrinology & Diabetes
  47. Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type 2 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan
    Ruriko Koto, Akihiro Nakajima, Tetsuya Miwa, Ken Sugimoto · 2023 · Diabetes Therapy
  48. The Role of Epigenetic Modifications in Late Complications in Type 1 Diabetes
    Barbara Čugalj Kern, Katarina Trebušak Podkrajšek, Jernej Kovač, Robert Šket, Barbara Jenko Bizjan, Tine Tesovnik, Maruša Debeljak, Tadej Battelino, Nataša Bratina · 2022 · Genes
  49. Use of Glucose-Lowering Agents in Diabetes and CKD
    Radica Z. Alicic, Joshua J. Neumiller, Rodolfo Javier Galindo, Katherine R. Tuttle · 2022 · Kidney International Reports
  50. Hypoglycaemia in type 1 diabetes mellitus: risks and practical prevention strategies
    Jasleen Kaur, Elizabeth R. Seaquist · 2022 · Nature Reviews Endocrinology
  51. Efficacy and safety of enavogliflozin, a novel SGLT2 inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase III trial
    Soo Heon Kwak, Kyung Ah Han, Kyung‐Soo Kim, Jae Myung Yu, Eun-Sook Kim, Jong Chul Won, Jun Goo Kang, Choon Hee Chung, Seungjoon Oh, Sung Hee Choi et al. · 2023 · Diabetes Obesity and Metabolism
  52. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients
    Catherine E. Price, Jessica E Fanelli, Joseph Aloi, Saskia C. Anzola, Susan R. Vishneski, Amit K. Saha, Christopher Woody, Scott Segal · 2023 · Journal of Clinical Anesthesia
  53. Narrative Review of Glycemic Management in People With Diabetes on Peritoneal Dialysis
    Piyumi Sachindra Alwis Wijewickrama, Jennifer K. Williams, Steve C Bain, Indranil Dasgupta, Tahseen Ahmad Chowdhury, Mona M. Wahba, Andrew Frankel, Mark Lambie, Janaka J. Karalliedde, Steve C Bain et al. · 2023 · Kidney International Reports
  54. Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”
    Dmitry S. Karpov, Anastasiia O. Sosnovtseva, Svetlana V. Pylina, Asya Bastrich, Darya A. Petrova, Maxim A. Kovalev, Anastasija I. Shuvalova, Еремкина Анна Константиновна, Natalia G. Mokrysheva · 2023 · International Journal of Molecular Sciences
  55. Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study
    Xianhua Mao, Ka Shing Cheung, Jing Tong Tan, Lung‐Yi Mak, Chi‐Ho Lee, Chi‐Leung Chiang, Ho Ming Cheng, Rex Wan‐Hin Hui, Man‐Fung Yuen, Wai K. Leung et al. · 2024 · Gut
  56. Carotid intima-media thickness, cardiovascular disease, and risk factors in 29,000 UK Biobank adults
    Sayan Mitra, Raaj Kishore Biswas, Petra T. E. Hooijenga, Sophie Cassidy, Andrea Nova, Isabella De Ciutiis, Tian Wang, Cynthia M. Kroeger, Emmanuel Stamatakis, Andrius Masedunskas et al. · 2025 · American Journal of Preventive Cardiology
  57. Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus
    PHILIP A. LEVIN, Byron J. Hoogwerf, Janet K. Snell‐Bergeon, Tim Vigers, Laura L. Pyle, Lee A. Bromberger · 2020 · Endocrine Practice
  58. Clinical profiles of diabetic foot ulcer patients undergoing major limb amputation at a tertiary care center in North-eastern Tanzania
    Ahmed Ali Shabhay, Pius Gerald Horumpende, Zarina Ali Shabhay, Andrew Mganga, Jeff Van Baal, David Msuya, Kondo Chilonga, Samwel Chugulu · 2021 · BMC Surgery
  59. Glucagon: Its evolving role in the management of hypoglycemia
    Diana M. Isaacs, Jennifer Nicole Clements, Neil Turco, Rachel Hartman · 2021 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  60. Personalized insulin dose manipulation attack and its detection using interval-based temporal patterns and machine learning algorithms
    Tamar Levy-Loboda, Eitam Sheetrit, Idit F. Liberty, Alon Haim, Nir Nissim · 2022 · Journal of Biomedical Informatics
  61. Long‐term cost‐effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the <scp>United States</scp>
    Valentine, William J., Hoog, Meredith, Mody, Reema, Belger, Mark, Pollock, Richard · 2023 · Diabetes, Obesity and Metabolism
  62. Higher Blood Glucose Levels on the Day of Surgery Are Associated with an Increased Risk of Periprosthetic Joint Infection After Total Hip Arthroplasty
    Julian R. Wier, Kevin C. Liu, Mary K. Richardson, Brandon S. Gettleman, Natalie M. Kistler, Nathanael D. Heckmann, Jay R. Lieberman · 2023 · Journal of Bone and Joint Surgery
  63. Poor glycemic control is associated with significant increase in major limb amputation and adverse events in the 30-day postoperative period after infrainguinal bypass
    Katharine L. McGinigle, Daniel G. Kindell, Paula Diane Strassle, Jason R. Crowner, Luigi E. Pascarella, Mark A. Farber, William A. Marston, Shipra Arya, Corey Andrew Kalbaugh · 2020 · Journal of Vascular Surgery
  64. Assessing telehealth interventions for physical activity and sedentary behavior self‐management in adults with type 2 diabetes mellitus: An integrative review
    Chelsea Howland, Bonnie J. Wakefield · 2020 · Research in Nursing & Health
  65. Real-Life Prescribing of SGLT2 Inhibitors: How to Handle the Other Medications, Including Glucose-Lowering Drugs and Diuretics
    David Wing-Hang Lam, Aisha Shaikh · 2021 · Kidney360
  66. Glucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease
    Connie M. Rhee, Csaba Pal Kovesdy, Kamyar Kalantar‐Zadeh · 2021 · Seminars in Nephrology
  67. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes
    Heather Ulrich, Monica M. Bowen · 2021 · Journal of the American Pharmacists Association
  68. HbA1c Variability and the Risk of Dementia in Patients with Diabetes: A Meta‐Analysis
    Jingjing Song, Hongying Bai, Hui Xu, Yuanyuan Xing, Si Chen · 2022 · International Journal of Clinical Practice
  69. Hyperglycemia and hypoglycemia exposure are differentially associated with micro- and macrovascular complications in adults with Type 1 Diabetes
    Alex Mesa, Marga Giménez, Irene Pueyo, Verónica Perea, Clara Viñals, Jesús Blanco, Irene Vinagre, Tonet Serés‐Noriega, Laura Boswell, Enric Esmatjes et al. · 2022 · Diabetes Research and Clinical Practice
  70. Automated Insulin Delivery for Pregnant Women With Type 1 Diabetes: Where Do We Stand?
    Katrien Benhalima, JOHAN H. JENDLE, Kaat Beunen, Lene Ringholm · 2024 · Journal of Diabetes Science and Technology
  71. Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus
    Natália Lavrado, Gil Fernando Salles, Claudia R.L. Cardoso, Paulo Henrique Condeixa de França, Maria Fernanda Di Guimarães Gonçalves Melo, Nathalie Carvalho Leite, Cristiane Alves Villela‐Nogueira · 2024 · Liver International
  72. Glucagon prescribing and costs among U.S. Adults with diabetes, 2011–2021
    Herges, Joseph R., Galindo, Rodolfo J., Neumiller, Joshua J., Heien, Herbert C., Umpierrez, Guillermo E., McCoy, Rozalina G. · 2023 · Diabetes Care
  73. Association between the Systemic Immune-Inflammation Index and Thyroid Function in U.S. Adults
    Xinyu Hu, Ying-Chao Liang, Huan-Huan Zhang, Hui-Lin Li, Deliang Liu · 2023 · Mediators of Inflammation
  74. Continuous glucose monitoring for automatic real-time assessment of eating events and nutrition: a scoping review
    Julian Brummer, Christina Glasbrenner, Sieglinde Hechenbichler Figueroa, Karsten Koehler, Christoph Höchsmann · 2024 · Frontiers in Nutrition
  75. From Control to Cure: Insights into the Synergy of Glycemic and Antibiotic Management in Modulating the Severity and Outcomes of Diabetic Foot Ulcers
    Idris Ajibola Omotosho, Noorasyikin Shamsuddin, Hasniza Zaman Huri, Wei Lim Chong, Inayat Ur Rehman · 2025 · International Journal of Molecular Sciences
  76. Identification of hyperglycemia-associated microbiota alterations in saliva and gingival sulcus
    Yushan Wei, Ya-Chun Hsiao, Guan-Wei Su, Yi‐Ru Chang, Hsiu-Pin Lin, Yi‐Shiuan Wang, Yi-Ting Tsai, En‐Chi Liao, Hsin‐Yi Chen, Hsiu‐Chuan Chou et al. · 2020 · Archives of Biochemistry and Biophysics
  77. The Effect of Diabetes and Prediabetes on Antituberculosis Treatment Outcomes: A Multicenter Prospective Cohort Study
    María B. Arriaga, Mariana Araújo‐Pereira, Beatriz Barreto‐Duarte, Betânia M. F. Nogueira, Maria Vitória C.N.S. Freire, Artur T. L. Queiroz, Moreno Magalhães de Souza Rodrigues, Michael S. Rocha, Alexandra B. Souza, Renata Spener-Gomes et al. · 2021 · The Journal of Infectious Diseases
  78. Twenty-four-hour movement guidelines during middle adolescence and their association with glucose outcomes and type 2 diabetes mellitus in adulthood
    Antônio García‐Hermoso, José Francisco López‐Gil, Yasmín Ezzatvar, Robinson Ramírez‐Vélez, Míkel Izquierdo · 2022 · Journal of sport and health science/Journal of Sport and Health Science
  79. Hybrid Closed Loop Using a Do-It-Yourself Artificial Pancreas System in Adults With Type 1 Diabetes
    Natalie Nanayakkara, Amin Sharifi, David Burren, Yasser Elghattis, Dulari K. Jayarathna, Neale D. Cohen · 2023 · Journal of Diabetes Science and Technology
  80. Degree of Joint Risk Factor Control and Incident Heart Failure in Hypertensive Patients
    Minghao Kou, Xuan Wang, Hao Ma, Xiang Li, Yoriko Heianza, Lu Qi · 2023 · JACC Heart Failure
  81. Remote Patient Monitoring in Diabetes: How to Acquire, Manage, and Use All of the Data
    Johnson, Eric L., Miller, Eden · 2022 · Diabetes Spectrum
  82. Unlocking Potential: Personalized Lifestyle Therapy for Type 2 Diabetes Through a Predictive Algorithm-Driven Digital Therapeutic
    Swantje Kannenberg, Jenny Voggel, Nils Thieme, Oliver Witt, Kim Lina Pethahn, Morten Schütt, Christian Sina, Guido Freckmann, Torsten Schröder · 2024 · Journal of Diabetes Science and Technology
  83. Efficacy and safety of automated insulin delivery in children aged 2–6 years (LENNY): an open-label, multicentre, randomised, crossover trial
    Tadej Battelino, Salla Kuusela, Ambika Shetty, Ivana Rabbone, Valentino Cherubini, Fiona Campbell, Ritva Ahomäki, Anna‐Kaisa Tuomaala, Catherine J. Peters, Dario Iafusco et al. · 2025 · The Lancet Diabetes & Endocrinology
  84. Diabetes Distress, Depressive Symptoms, and Cardiovascular Health in Adults With Type 1 Diabetes
    Margaret M. McCarthy, Robin Whittemore, Georica Gholson, Margaret J. Grey · 2019 · Nursing Research
  85. Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes
    Artemis Kyriakidou, Angeliki V. Kyriazou, Theocharis Koufakis, Yiannis Vasilopoulos, Maria Grammatiki, Xanthippi Tsekmekidou, Iakovos Avramidis, S. Baltagiannis, Dimitrios G. Goulis, Pantelis E Zebekakis et al. · 2022 · Journal of Personalized Medicine
  86. Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
    Yihong Deng, Eric C. Polley, Joshua David Wallach, Sanket Shishir Dhruva, Jeph S. Herrin, Kenneth Quinto, Charu Gandotra, William H. Crown, Peter A. Noseworthy, Xiaoxi Yao et al. · 2022 · BMJ
  87. Comparison of beta-cell function between Hong Kong Chinese with young-onset type 2 diabetes and late-onset type 2 diabetes
    Yingnan Fan, Baoqi Fan, Eric S. H. Lau, Cadmon K.P. Lim, Hongjiang Wu, Ronald C.W., Risa Ozaki, Alice P.S. Kong, Elaine Chow, Andrea O. Y. Luk et al. · 2023 · Diabetes Research and Clinical Practice
  88. Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement
    Kalyani, Rita R, Allende-Vigo, Myriam Z, Antinori-Lent, Kellie J, Close, Kelly L, Das, Sandeep R, Deroze, Phyllisa, Edelman, Steven V, El Sayed, Nuha A, Kerr, David, Neumiller, Joshua J et al. · 2024 · The Journal of Clinical Endocrinology &amp; Metabolism
  89. Prediabetes and poorly controlled type-2 diabetes as risk indicators for peri-implant diseases:A systematic review and meta-analysis
    Bulcsú Bencze, Bianca Gólzio Navarro Cavalcante, Mario Romandini, Virág Róna, Szilárd Váncsa, Gábor Varga, Márton Kivovics, Bence Szabó, Gergely Agócs, Zoltán Géczi et al. · 2024 · Journal of Dentistry
  90. Hypoglycemia and hospital mortality in critically ill patients
    H. Yeh, Wen-Cheng Chao, Chieh‐Liang Wu, Ming-Cheng Chan · 2025 · Scientific Reports
  91. Natural daylight during office hours improves glucose control and whole-body substrate metabolism
    Jan‐Frieder Harmsen, Ivo Habets, Andrew D. Biancolin, Agata Lesniewska, Nick E. Phillips, Loic Metz, Juan Sánchez-Ávila, Marit Kotte, Merel Timmermans, Dzhansel Hashim et al. · 2025 · Cell Metabolism
  92. Increased Presentation of Diabetic Ketoacidosis and Changes in Age and Month of Type 1 Diabetes at Onset during the COVID-19 Pandemic in Spain
    Isabel Leiva Gea, Cristina Antúnez Fernández, Roque Cardona‐Hernandez, Marta Ferrer Lozano, Pilar Bahillo-Curieses, Javier Arroyo-Díez, María Clemente, María Martín-Frías, Santiago Conde Barreiro, Andrés Mingorance Delgado et al. · 2022 · Journal of Clinical Medicine
  93. The Effect of Cognitive Behavioral Therapy for Insomnia (CBT-I) on Cardiometabolic Health Biomarkers: A Systematic Review of Randomized Controlled Trials
    Kimberly L. Savin, Taylor L. Clark, Perla Perez-Ramirez, Tara Shrout Allen, Maíra Tristão Parra, Linda C. Gallo · 2022 · Behavioral Sleep Medicine
  94. Clinical Decision Support System for Diabetic Patients by Predicting Type 2 Diabetes Using Machine Learning Algorithms
    Rakibul Islam, Azrin Sultana, Md. Nuruzzaman Tuhin, Md. Sazzad Hossain Saikat, Mohammad Rashedul Islam · 2023 · Journal of Healthcare Engineering
  95. Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
    Linong Ji, Rikke Mette Agesen, Stephen Charles Bain, Fangming Fu, Sanaz Gabery, Jianlin Geng, Yiming Li, Yibing Lu, Bifen Luo, Wuyan Pang et al. · 2024 · Diabetologia
  96. Same goals, different challenges: A systematic review of perspectives of people with diabetes and healthcare professionals on Type 2 diabetes care
    Soraia de Camargo Catapan, Uthara Nair, Len Gray, Maria Cristina Marino Calvo, Dominique Bird, Monika Janda, Farhad Fatehi, Anish Menon, Anthony William Russell · 2021 · Diabetic Medicine
  97. Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients
    Yaxin Wang, Jingyi Lu, Yun Shen, Jiaying Ni, Lei Zhang, Wei Lu, Wei Zhu, Yuqian Bao, Jian Zhou · 2022 · Journal of Diabetes Investigation
  98. Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial
    Thomas Rudolf Pieber, Kristine Niss Arfelt, Roman Cailleteau, Marlies Hart, Soumitra Kar, Ines Mursic, Eva Švehlíková, Martina Urschitz, Hanne L. Haahr · 2023 · Diabetologia
  99. Effect of semaglutide on kidney function across different levels of baseline HbA1c, blood pressure, body weight and albuminuria in SUSTAIN 6 and PIONEER 6
    Ellen M. Apperloo, David Z.I. Cherney, Anja Birk Kuhlman, Johannes F.E. Mann, Søren Rasmussen, Peter R Rossing, Katherine R. Tuttle, Blaz Vrhnjak, Hiddo J.L. Heerspink · 2024 · Nephrology Dialysis Transplantation
  100. The value of glycated hemoglobin as predictor of organ dysfunction in patients with sepsis
    Young Seok Lee, Kyung Hoon Min, Sung Yong Lee, Jae Jeong Shim, Kyung Ho Kang, Woo Hyun Cho, Doosoo Jeon, Yun Seong Kim · 2019 · PLoS ONE